Literature DB >> 20700815

A case of neuromyelitis optica developing into myelitis 25 years after optic neuritis.

Mikihide Ogasawara, Keigo Shikishima, Tsutomu Sakai, Mineo Takagi, Keiko Tanaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20700815     DOI: 10.1007/s10384-010-0818-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  6 in total

1.  The clinical course of neuromyelitis optica (Devic's syndrome).

Authors:  D M Wingerchuk; W F Hogancamp; P C O'Brien; B G Weinshenker
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

2.  NMO antibody-positive recurrent optic neuritis without clear evidence of transverse myelitis.

Authors:  Marc J Dinkin; Dean M Cestari; Marion C Stein; Steve D Brass; Simmons Lessell
Journal:  Arch Ophthalmol       Date:  2008-04

3.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

4.  Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions.

Authors:  K Tanaka; T Tani; M Tanaka; T Saida; J Idezuka; M Yamazaki; M Tsujita; T Nakada; K Sakimura; M Nishizawa
Journal:  Mult Scler       Date:  2007-04-27       Impact factor: 6.312

5.  NMO-IgG predicts the outcome of recurrent optic neuritis.

Authors:  M Matiello; V A Lennon; A Jacob; S J Pittock; C F Lucchinetti; D M Wingerchuk; B G Weinshenker
Journal:  Neurology       Date:  2008-04-23       Impact factor: 9.910

6.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

  6 in total
  1 in total

1.  Anti-aquaporin-4 antibody-positive familial neuromyelitis optica in mother and daughter.

Authors:  Shoyo Yoshimine; Tsutomu Sakai; Mikihide Ogasawara; Keigo Shikishima; Hiroshi Tsuneoka; Keiko Tanaka
Journal:  Jpn J Ophthalmol       Date:  2011-09-09       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.